Subscribe to our Newsletters !!

    indian business news

    Johnson and Johnson’s COVID-19 immunization produces solid invulnerable reaction in early preliminary

    Pharmaceutical giant Johnson & Johnson’s experimental COVID-19 vaccine has produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, in accordance with the data published on September 25. “The data demonstrate that a single dose of COVID-19 vaccine, Ad26.COV2.S, induced a powerful neutralising antibody response in nearly all participants aged